Monoclonal Autoantibody Against a Cryptic Epitope on Tissue-Adherent Low-Density Lipoprotein for Molecular Imaging in Atherosclerosis.

[1]  F. Jaffer,et al.  Intravascular Molecular-Structural Assessment of Arterial Inflammation in Preclinical Atherosclerosis Progression. , 2021, JACC. Cardiovascular imaging.

[2]  Habib Samady,et al.  Identification of patients and plaques vulnerable to future coronary events with near-infrared spectroscopy intravascular ultrasound imaging: a prospective, cohort study , 2019, The Lancet.

[3]  Torsten Schwede,et al.  SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..

[4]  P. Matthews,et al.  Near Infrared Fluorescence (NIRF) Molecular Imaging of Oxidized LDL with an Autoantibody in Experimental Atherosclerosis , 2016, Scientific Reports.

[5]  R. Edwards,et al.  Model IgG monoclonal autoantibody-anti-idiotype pair for dissecting the humoral immune response to oxidized low density lipoprotein. , 2012, Hybridoma.

[6]  P. D. de Groot,et al.  Beta2-glycoprotein I can exist in 2 conformations: implications for our understanding of the antiphospholipid syndrome. , 2010, Blood.

[7]  M. Sternberg,et al.  Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.

[8]  S. Gordon,et al.  Macrophage scavenger receptors and host-derived ligands. , 2007, Methods.

[9]  P. D. de Groot,et al.  Pathogenic anti-beta2-glycoprotein I antibodies recognize domain I of beta2-glycoprotein I only after a conformational change. , 2006, Blood.

[10]  G. Pasterkamp,et al.  Athero-express: Differential atherosclerotic plaque expression of mRNA and protein in relation to cardiovascular events and patient characteristics. Rationale and design , 2004, European Journal of Epidemiology.

[11]  P. Shah,et al.  Inhibition of Atherosclerosis in ApoE-Null Mice by Immunization with ApoB-100 Peptide Sequences , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[12]  G. Berglund,et al.  Identification of Immune Responses Against Aldehyde-Modified Peptide Sequences in ApoB Associated With Cardiovascular Disease , 2003, Arteriosclerosis, thrombosis, and vascular biology.

[13]  J. Borén,et al.  Subendothelial retention of atherogenic lipoproteins in early atherosclerosis , 2002, Nature.

[14]  J. Segrest,et al.  Structure of apolipoprotein B-100 in low density lipoproteins. , 2001, Journal of lipid research.

[15]  M. Carrier,et al.  Distribution of Lipid Deposits Around Aortic Branches of Mice Lacking LDL Receptors and Apolipoprotein E , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[16]  John M. Hancock,et al.  The structure of vitellogenin provides a molecular model for the assembly and secretion of atherogenic lipoproteins. , 1999, Journal of molecular biology.

[17]  M. Ferguson,et al.  Comparison of apolipoprotein and proteoglycan deposits in human coronary atherosclerotic plaques: colocalization of biglycan with apolipoproteins. , 1998, Circulation.

[18]  S. Bhakdi,et al.  On the pathogenesis of atherosclerosis: enzymatic transformation of human low density lipoprotein to an atherogenic moiety , 1995, The Journal of experimental medicine.

[19]  G. Bondjers,et al.  Modifications of low-density lipoprotein induced by arterial proteoglycans and chondroitin-6-sulfate. , 1991, Biochimica et biophysica acta.

[20]  A. Gotto,et al.  Isolation and characterization of sulfhydryl and disulfide peptides of human apolipoprotein B-100. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[21]  L. Romics,et al.  Binding of fibronectin to human lipoproteins. , 1989, Clinica chimica acta; international journal of clinical chemistry.

[22]  J. Archer,et al.  Cross-reactivity between solid-phase immunoassay plates and intermediate filaments demonstrated by human monoclonal antibodies. , 1985, Journal of immunological methods.

[23]  G. Camejo,et al.  The structural stability of low-density lipoprotein. A kinetic X-ray scattering study of its interaction with arterial proteoglycans. , 1984, Biochimica et biophysica acta.

[24]  M. Bihari-varga,et al.  Changes in the physical behavior of low density lipoprotein in the presence of glycosaminoglycans and high density lipoprotein. , 1981, Atherosclerosis.